openPR Logo
Press release

Europe Precision Diagnostics Market Size is Expected to Reach US$ 59.30 Billion by 2031, Rising at a Market Growth of 11.4% CAGR During the Forecast Period

09-26-2025 06:31 AM CET | Health & Medicine

Press release from: Persistence Market Research

Europe Precision Diagnostics Market Size is Expected to Reach

The Europe precision diagnostics market plays a pivotal role in advancing personalized healthcare by enabling early detection, accurate disease profiling, and tailored treatment pathways. Precision diagnostics leverage advanced technologies such as genomics, proteomics, digital pathology, molecular diagnostics, and AI-driven tools to improve patient outcomes and reduce healthcare costs. Growing emphasis on early disease intervention, rising prevalence of chronic and genetic disorders, and the increasing adoption of digital health solutions are driving the market forward.

Request a Sample: https://www.persistencemarketresearch.com/samples/34894

According to the latest study by Persistence Market Research, the Europe precision diagnostics market is estimated to rise from US$ 27.85 Bn in 2024 to US$ 59.30 Bn by 2031. The market is projected to record a CAGR of 11.4% during the forecast period from 2024 to 2031. Growth is further fueled by Europe's robust healthcare infrastructure, supportive regulatory policies, and strong focus on sustainable healthcare innovation.

Market expansion is supported by rising demand for advanced cancer diagnostics, companion diagnostics in personalized therapies, and infectious disease testing solutions. Genomic testing and next-generation sequencing (NGS) are emerging as the leading technologies, offering critical insights for targeted therapies. Geographically, Western Europe dominates the market due to high R&D spending, adoption of advanced diagnostic platforms, and supportive reimbursement frameworks in countries like Germany, the UK, and France.

For More Information:
https://www.persistencemarketresearch.com/market-research/europe-precision-diagnostics-market.asp

Key Market Insights

The Europe precision diagnostics market is estimated to rise from US$ 27.85 Bn in 2024 to US$ 59.30 Bn by 2031

Genomic and molecular diagnostics dominate the technology segment, driven by adoption in oncology and rare disease testing.

Western Europe remains the leading region, supported by advanced healthcare infrastructure and policy support.

Rising demand for companion diagnostics and personalized treatment pathways is shaping the market.

AI and digital pathology integration are creating new opportunities in early disease detection and workflow optimization.

What are the main drivers of the Europe precision diagnostics market?

The primary drivers include the rising prevalence of cancer and genetic diseases, increased adoption of personalized medicine, and the expansion of NGS and molecular diagnostics. Growing investments in healthcare digitalization, coupled with AI-powered diagnostic platforms, are enhancing accuracy and efficiency. Additionally, favorable government initiatives across Europe-such as funding for genomic medicine programs and adoption of precision oncology pathways-are fueling market growth.

Market Dynamics

Drivers:

Increasing demand for personalized and preventive healthcare.

Rapid adoption of molecular diagnostics and NGS technologies.

Government support through funding and genomic medicine initiatives.

Rising focus on early disease detection and chronic disease management.

Market Restraining Factor:

High cost of precision diagnostic platforms and tests.

Data privacy concerns in genomics and AI-based diagnostics.

Complex regulatory approval processes across European countries.

Key Market Opportunity:

Expansion of AI-driven precision diagnostics and digital pathology.

Growing role of liquid biopsy in cancer screening.

Rising collaborations between pharma and diagnostic companies for companion diagnostics.

Market Segmentation

By Type

Genetic Tests
Direct to Consumer Tests
Esoteric Tests

By Application

Oncology
Respiratory Diseases
Skin Diseases
CNS Disorders

By End Use

Hospitals
Clinical Laboratories

By Country

U.K.
Germany
France
Italy
Spain
Russia

Regional Insights

Western Europe dominates the regional landscape, led by Germany, the UK, and France. Strong healthcare infrastructure, high diagnostic spending, and established reimbursement frameworks support market leadership.

Northern Europe is experiencing steady growth, driven by digital healthcare adoption and genomic research programs in countries like Sweden, Denmark, and Finland.

Southern Europe markets, including Italy and Spain, are expanding due to rising investments in oncology and rare disease diagnostics.

Eastern Europe is emerging, with countries like Poland and Hungary gradually adopting advanced diagnostic solutions supported by EU healthcare funding.

Competitive Landscape

The Europe precision diagnostics market is competitive, with global and regional players investing in technological innovation, strategic collaborations, and expansion into emerging healthcare systems.

Company Insights

✦ Roche Diagnostics
✦ Siemens Healthineers
✦ Illumina, Inc.
✦ Qiagen N.V.
✦ Thermo Fisher Scientific
✦ Agilent Technologies
✦ BioMérieux SA
✦ Foundation Medicine (Roche subsidiary)
✦ Beckman Coulter (Danaher)
✦ Guardant Health

Key Industry Developments

Leading companies are focusing on integrating AI and machine learning into diagnostic workflows for faster, more accurate results.

Expansion of companion diagnostics partnerships between pharma and diagnostic providers is reshaping oncology testing.

Investment in liquid biopsy solutions is gaining traction for minimally invasive cancer detection.

Companies like Roche and Illumina are investing in genomic data platforms to strengthen personalized medicine adoption in Europe.

Innovation and Future Trends

The future of the Europe precision diagnostics market lies in genomics-driven medicine, digital healthcare integration, and AI-powered diagnostics. Widespread adoption of liquid biopsy, multi-cancer early detection (MCED) tests, and cloud-based diagnostic platforms is expected to transform the healthcare landscape. Precision oncology and rare disease diagnostics will remain key focus areas, while bioinformatics and big data analytics will enable deeper insights into population health.

Long-term growth will be shaped by cross-industry collaborations, where diagnostic companies, pharma players, and digital health providers work together to deliver value-based, patient-centric healthcare solutions.

More Related Report:

Wound Cleanser Products Market- https://www.persistencemarketresearch.com/market-research/wound-cleanser-products-market.asp
Atomic Magnetometers Market- https://www.persistencemarketresearch.com/market-research/atomic-magnetometers-market.asp

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Precision Diagnostics Market Size is Expected to Reach US$ 59.30 Billion by 2031, Rising at a Market Growth of 11.4% CAGR During the Forecast Period here

News-ID: 4198824 • Views:

More Releases from Persistence Market Research

Functional Endoscopic Sinus Surgery Market Size Worth $2.5 Billion By 2032
Functional Endoscopic Sinus Surgery Market Size Worth $2.5 Billion By 2032
The functional endoscopic sinus surgery (FESS) market plays a vital role in advancing minimally invasive treatment options for chronic sinusitis, nasal polyps, and other complex sinus disorders. FESS has emerged as the gold standard procedure due to its ability to restore normal sinus ventilation and drainage with reduced recovery times, fewer complications, and improved patient outcomes compared to traditional surgical approaches. Request a Sample: https://www.persistencemarketresearch.com/samples/35558 According to the latest study
Peritoneal Dialysis Market Expected to Witness Impressive Growth at a 9.7% CAGR by 2032, PMR Report
Peritoneal Dialysis Market Expected to Witness Impressive Growth at a 9.7% CAGR …
The peritoneal dialysis market plays a critical role in offering effective renal replacement therapy for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Unlike hemodialysis, peritoneal dialysis (PD) allows patients to perform treatment at home, offering greater flexibility, cost-effectiveness, and improved quality of life. According to the latest study by Persistence Market Research, the peritoneal dialysis market size is likely to be valued at US$ 6.1 Bn
Immunodiagnostics Market Size to Hit USD 38.1 Billion in 2032, expanding at a CAGR of 7.2% | PMR Report
Immunodiagnostics Market Size to Hit USD 38.1 Billion in 2032, expanding at a CA …
The immunodiagnostics market plays a vital role in modern healthcare by enabling accurate detection, monitoring, and management of infectious diseases, cancer, autoimmune disorders, and other chronic conditions. Immunoassays, a core part of this market, are widely used in clinical laboratories, hospitals, and point-of-care testing (POCT) settings. They provide high sensitivity and specificity, making them indispensable in disease diagnosis and therapeutic monitoring. Request a Sample: https://www.persistencemarketresearch.com/samples/35549 According to the latest study by
U.S. Hemostats Market Expected to Witness Impressive Growth at a 6.5% CAGR by 2032, PMR Report
U.S. Hemostats Market Expected to Witness Impressive Growth at a 6.5% CAGR by 20 …
The U.S. hemostats market plays a vital role in modern surgical care by providing rapid bleeding control and enhancing patient safety across a wide range of medical procedures. Hemostatic agents and devices are extensively used in general surgery, cardiovascular surgery, orthopedic procedures, trauma care, and dental applications. They help minimize blood loss, shorten operative time, and reduce complications, making them indispensable in hospitals, ambulatory surgical centers, and emergency settings. Request

All 5 Releases


More Releases for Europe

2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The key players covered in this study McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business. A new report as a Digital Strategy Consulting market that includes a comprehensive analysis
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • McKinsey • The Boston Consulting Group • Bain & Company • Booz & Co. • Roland Berger Europe • Oliver Wyman Europe • A.T. Kearney Europe • Deloitte • Accenture Europe Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB Market segment by Type, the product can be split into • Operations Consultants • Business Strategy Consultants • Investment Consultants • Sales and
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China. In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This